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ABSTRACT 
 Recent developments in healthcare economics literature suggest that various 
low-value healthcare services can be reliably detected through querying claims data; 
further, advances in the study of physician networks relationship with the cost and 
quality of care provoke the hypothesis that physician networks may be associated with 
the usage of low-value services. In this study, we investigate the distribution of low-
value cancer screening services amongst physician networks in 5 states, testing for 
differences between networks using econometric methods and exploring potential 
drivers of low-value service usage amongst networks. Using data mining techniques 
on 2008 Medicare claims data, we identify three low-value cancer screening services 
amongst 417 physician referral networks developed in prior research. A fixed effects 
negative binomial model and a multivariate regression model were used to test for 
significance of low-value service usage variation between networks and for 
investigating potential associative significance of network-level characteristics, 
respectively. We found statistically significant variation (p<.01) in the usage of two of 
the three cancer screening services between the physician networks after controlling 
for patient and physician characteristics. Additionally, we identified three network 
variables which significantly predict the dependent variable (low-value services per 
100 “at-risk” beneficiaries in the network): percentage of network physicians trained 
in the U.S.; percentage of physicians with an MD (compared to DO); and the mean-
adjusted valued degree (a measure for the level of “patient-sharing” within the 
network). 
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INTRODUCTION 
The purpose of this study is to investigate the relationship between physician 
networks—whether formal or organically occurring—and the usage of low value 
services. Given American healthcare policymaker’s objective to reduce expenditure 
while improving both quality of care and the patient experience, it is essential to 
identify inefficiencies in care delivery. Amongst inefficiencies in the healthcare sector, 
one which detracts from all three of the prior “objectives”, is the usage of low value 
services—those services which have been deemed to be of little-to-no clinical benefit 
to the patient. Research estimates have claimed that as much as 30% of healthcare 
expenditures in the United States are wasteful.(1) Unsurprisingly, the greatest driver of 
total healthcare expenditures is the national aggregate of physician’s clinical 
decisions—accounting for nearly 80% of healthcare spending(2). The prevalence and 
patterns of low-value services’ usage amongst physicians and their referral networks, 
as well as the potential drivers of their usage, are of interest to healthcare policy 
researchers, commercial and public payers, and providers alike because they provide 
the market with a potential means to reduce wasteful spending and possibly improve 
both patient care and experience.  
During the past decade, a substantial effort from both public and private 
institutions and physician specialty groups has generated a wealth of published data 
regarding the specifications for “low-value” healthcare interventions.(3-5)  
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The National Institute of Health and Clinical Excellence (NICE) took initiative 
in 2007 to create a list of ‘do not do’ recommendations with specific clinical 
interventions which should not be performed under a set of restrictive criteria.(6, 7)  
Since then, the American Board of Internal Medicine (ABIM) has worked with 
Consumer Reports to release lists of the “top five” low value medical “treatments” for 
each of twenty-six physician specialties as well as additional state-level physician 
organizations as part of the Choosing Wisely campaign.(8, 9) Independent from the 
ABIM, since 2007 the U.S. Preventive Services Task Force (USPSTF) has released 
recommendations of medical interventions with usefulness ratings for primary care 
providers; they identify services which are of no benefit to the patient (or may even do 
more harm than good) as grade D services (on a scale from A to D).(10)    Though 
there are hundreds of clinical-context definitions of low-value services in published 
medical journals, a proper methodology for the retrospective identification of these 
services has proven illusory until only recently.  
As mentioned earlier, academic, peer-reviewed medical literature is replete 
with the criteria for defining constitutions of low-value services. Typically, a low 
value service is defined by some or all the following criteria: the type of service 
(procedure, or intervention); the age, sex, and medical history (chronic conditions, 
prior testing, etc.) of the patient; the frequency of service received by a patient; and the 
medical diagnosis of the patient, often in conjunction with the other criteria. In a 
present clinical context, it would be relatively simple for a medical professional to 
identify a service as low-value, however, the insurance claims data supplied to 
healthcare researchers for identifying low-value care is retrospective data originally 
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intended for billing purposes, which presents researchers with various challenges.(11, 
12) The criteria necessary to confidently detect a low-value service based on claims 
data is often either too detailed (and thus not found in the claims data), or too 
subjective in nature to identify the instance of a low-value service. A few studies have 
defined which low-value services could be identified based upon data available within 
Medicare claims. A seminal study of Medicare claims completed by Colla, et al. found 
that there was significant variation in usage of eleven low-value services (all from 
Choosing Wisely) across hospital referral regions in the United States.(13) The level of 
sensitivity for their low-value service detection rate is not estimated, but the selection 
methodology used to choose the eleven studied services was rigorous. Prior research 
from Schwartz, et al. has identified thirty-one low-value services which can be 
confidently identified in Medicare claims data with a high level of specificity.(14) 
In recent years, the identification of physician referral networks, irrespective of 
formal healthcare delivery organizations, has been studied using social network theory 
and claims-based network detection modeling.(11, 15) These networks have shown 
meaningful variance in both healthcare quality and costs, though no variable has been 
identified as the driver of differentiation between networks (15, 16). Prior research 
lends strong credibility to the idea that physician referral networks may influence 
patterns of care delivery (12, 17), so investigating the relationship between physician 
referral networks and the usage of low value services is important to advance the 
understanding of wasteful medical care drivers.  
Until recently, it was only speculated that low-value care delivery could be 
reduced through “pay-for-performance” (PFP) incentives programs; a study by 
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Schwartz, et al. measured the change in usage of low-value services before and after a 
an experimental group enrolled in a PFP contract with Medicare which either 
rewarded or penalized physicians based upon scores of cost and quality, etc. Their 
research, using difference in differences time series analysis has found that physician 
groups participating in the Medicare Pioneer ACO Program significantly reduced their 
usage of low-value care compared to groups of non-ACO physicians; we can say with 
some confidence that physicians, if prompted with an effective stimulus, can change 
clinical decision making practices—creating an impetus for further research upon the 
influence of care-delivery patterns, and the efficacy of health policy interventions and 
compensation packages seeking to reduce wasteful spending on low-value 
services(18). 
 It is our intention to elucidate the association or lack thereof between 
physician networks and the usage of low-value cancer screening services in this study 
so that physician organization leaders, payers, and researchers, amongst others, might 
develop a better understanding of what role physician networks play in their respective 
healthcare markets. In our study, we identify low-value service usage amongst a 
Medicare population, attribute those beneficiaries to their respective physician 
networks, and analyze econometric models to decipher variation of usage between 
physician networks and the potential drivers which might cause one network to deliver 
more low-value services than another. We hypothesize that there is variation in low-
value cancer screening services amongst our study population of 417 networks.   
 
 
 5 
 
Methods 
Study Population 
Building upon the work of Casalino, et al. we identified and attributed three 
“at-risk for low-value services” beneficiary populations to 417 physician practice 
communities for each of three low-value cancer screening services. The beneficiary 
population was drawn from a random sample of 987,000 Medicare fee-for-service 
enrolled beneficiaries from 5 states (Ohio, Pennsylvania, Tennessee, Washington, 
Wisconsin), alive at the end of the study-year, at least 65 years old, and not in the 
Medicare End-Stage Renal Disease Program in 2008. Amongst the three study 
populations, there is significant overlap of “at-risk” patient populations and physicians 
between Low-Value Service (LVS) #1 and LVS # 3, and between “at-risk” patient 
populations and physicians LVS #2 and #3, while patient populations #2 and #3 are 
exclusive of one another due to gender delineation. Networks vary amongst 
populations dependent upon the parameters for each respective “at-risk” populations 
defined by Schwartz, et al.(14, 18) Primary analysis was initially conducted based 
upon an aggregated population with “At-Risk for Low-Value Service #X”, however 
due to the dissimilarity of physicians and beneficiaries analyzed for each of the three 
services; this study is more appropriately suited to test each population independently.  
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Beneficiary Characteristics 
 We adjusted our analysis for commonly accepted beneficiary characteristics 
including: beneficiary age, sex, an indicator for Medicaid dual eligibility during 2008, 
and a socioeconomic status (SES) categorical variable. Zip code level per capita 
median income was used to develop a decile ranking of SES (excluded from 
descriptive statistics due to excessive volume of data). Beneficiary age, sex, and dual 
eligibility were derived from the Medicare annual beneficiary summary file. 
Physician Network Characteristics 
Physician practice community (PPC) characteristics which describe qualities of 
both commonly accepted physician quality measures and network composition were 
included.  PPC Characteristics include the percentage of physicians in the age groups: 
<40, 40-50, 51-60, >60; percentage of female physicians; percentage of DO physicians 
(compared to MD); percentage of physicians trained in the U.S. (compared to foreign 
medical schools); percent of physicians board certified; primary care physician 
percentage of network; Mean-adjusted valued degree; and the betweeness-centrality 
ratio, amongst others. The mean adjusted-valued degree is a descriptor of the average 
strength of ties (computed based upon the number and frequency of beneficiaries 
shared between physicians in the network) within each network. The mean 
betweeness-centrality network variable is a measure of the average “centrality” (how 
central a physician is as a connector of beneficiaries to other network-assigned 
physicians) of all physicians in the network. 
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Identifying Low-Value Services 
As described in the introduction, low-value services are medical services 
which deliver no clinical benefit to the beneficiary while increasing expenditure by 
payers (in this case, the payer is Medicare). Amongst the many low-value services 
listed and described by the literature, there is a subset which has been proven to be 
reliably identifiable from claims data—an intrinsically difficult data source to query 
for detailed clinical information.  
 In this study, we identify three low-value cancer screening services usage 
amongst physician practice communities: Prostate Specific Antigen testing amongst 
men over age 75, without a history of prostate cancer; Cervical Cancer Screening 
amongst women over age 65, without a history cervical and other relevant cancers or 
dysplasias; and Colon Cancer Screening for beneficiaries over the age of 85, without a 
history of colon cancer. The clinical definitions of these three cancer screens/tests are 
derived from the US Preventive Service Task Force and the Agency for Healthcare 
Research and Quality. (19-21) Patient Age, Sex, and Chronic Conditions 
History/Dates were accessed using the Chronic Conditions Warehouse.(22) HCPCS 
codes, diagnosis codes, and other clinical information were gathered from Outpatient 
claims, Inpatient claims, and the 2008 MEDPAR files. Physician characteristics (Age, 
Sex, certifications, etc.) were taken from the AMA Masterfile.  
We conducted the detection of low-value service usage using SQL and SAS 
data mining techniques and conducted statistical analysis using STATA v.14. In order 
to capture all beneficiaries at risk for one of the three services, we applied population 
restriction criteria as defined by Schwartz, et al.(14, 18) which defines populations 
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based on age, sex, chronic conditions, prior DRG codes. Amongst the three at-risk 
populations, we applied highly specific criteria to assign services as low-value based 
upon HCPCS codes, timing of service in relation to other services (using MEDPAR 
and Dates of Service in in/outpatient claims), and the setting of care (acute vs 
outpatient).  
The three low-value cancer screening services as defined in this paper each 
include multiple procedures which qualify as the low-value service. There were 11 
CPT codes qualifying as a Cervical Cancer Screenings; 38 CPT codes qualifying as a 
Colon Cancer Screening; and 4 CPT codes qualifying as a Prostate-Specific Antigen 
Screening. To calculate total costs for the three low-value services, we used a direct 
cost method, only including the cost of the screening test ordered.     
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RESULTS 
Study Population 
 Three separate at-risk populations were calculated based upon the at-risk for 
low-value service (LVS) criteria explained in the Methods section. Population 1 (At-
Risk for PSA LVS) contains 113,811 beneficiaries and 28,925 physicians attributed to 
416 networks; Population 2 (At-Risk for Cervical Screening LVS) contains 409,786 
beneficiaries and 44,867 physicians within 417 networks; and Population 3 (At-Risk 
for Colorectal Screening LVS) contains 100,690 beneficiaries and 26,538 physicians 
within 416 networks. Total LVS usage across all three populations were calculated; 
we detected 15,087 instances of LVS #1, 15,323 instances of LVS #2, and 3,167 
instances of LVS #3 (Table 1). Total costs for each LVS were computed using the 
direct cost of the screening service used; LVS #1 usage generated $452,610 in 
wasteful spending, LVS #2 usage generated $386,752 in wasteful spending, and LVS 
#3 generated $1,337,311 in wasteful spending (Table 1). Amongst the three 
populations, patients at risk for LVS #1 had the highest risk of receiving the LVS, as 
13.26% of all at-risk beneficiaries received the LVS (table 1). 
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  Table 1: Low Value Service Prevalence Amongst Each "At-Risk Population"   
  
Low-Value 
Service 
Beneficiaries At-
Risk for Service 
Beneficiaries Who 
Received LVS (Count, %) 
Total 
LVS 
Total Direct 
Cost   
  LVS 1 (PSA) 113,811 14,369 (13.26%) 15,087  $   452,610.00    
  LVS 2 (Cervical) 409,786 14,786 (3.74%) 15,323  $   386,752.52    
  LVS 3 (Colon) 100,690 3,167 (3.60%) 3,627  $1,337,311.17    
              
 
 Further descriptive statistics for each of the three at-risk patient populations are 
provided in Tables 2-4. 
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Table 2: Descriptive Statistics  for "At-Risk for LVS#1" Beneficiaries and Physicians Assigned 
to a PPC   
    Mean SD Minimum Maximum   
  Patient Level Characteristics (n=113,811)           
     Age 81.7 4.74 75.05 107.7   
     Female (%) 0 NA NA NA   
     Dual Eligible (min 1 mo.) (%) 8.42 NA NA NA   
     Race           
        White 95.42 NA NA NA   
        Black 3.12 NA NA NA   
        Hispanic 0.34 NA NA NA   
        Asian/Pacific Islander 0.67 NA NA NA   
        American Indian/Alaska Native 0.32 NA NA NA   
        Other Race/Ethnicity 0.14 NA NA NA   
     Mean LVS (#1) Per Beneficiary 0.1326 0.359 0 8   
  Physician-Level Characteristics (n=28,925)           
     Female (%) 10.08 NA NA NA   
     Age (%)           
        Under 40 Years 13.41 NA NA NA   
        40-50 Years 28.70 NA NA NA   
        51-60 Years 36.87 NA NA NA   
        Over 60 Years 21.02 NA NA NA   
     US Trained (%) 82.24 NA NA NA   
     Doctor of Osteo. (%) 10.31 NA NA NA   
  Network Characteristics (n=416)           
     Physician Female (%) 23.29 8.57 0 61.54   
     Physician US Trained (%) 76.64 11.2 30.43 100   
     Physician DO (%) 11.14 10.4 0 70.32   
     Physician Board Certified (%) 80.4 11.41 21.68 100   
     PCP (%) 42.5 11.56 6.3 90.32   
     "At-Risk" Beneficiaries Per PPC 273.58 226.53 2.00 2084.00   
     Physicians Per PPC (w/at-risk bene.) 69.53 48.72 2.00 285.00   
     Mean Adjusted Valued Degree 3.69 2.27 0.72 15.07   
     Betweeness-Centrality Ratio 1.18 1.28 0 14.76   
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Table 3: Descriptive Statistics for "At-Risk for LVS#2" Beneficiaries and Physicians Assigned 
to a PPC   
    Mean SD Minimum Maximum   
  Patient Level Characteristics (n=409,786)           
     Age 77.64 7.75 66 112   
     Female (%) 100 NA NA NA   
     Dual Eligible (min 1 mo.) (%) 15.46 NA NA NA   
     Race           
        White 93.38 NA NA NA   
        Black 4.99 NA NA NA   
        Hispanic 0.53 NA NA NA   
        Asian/Pacific Islander 0.7 NA NA NA   
        American Indian/Alaska Native 0.23 NA NA NA   
        Other Race/Ethnicity 0.18 NA NA NA   
     Mean LVS (#2) Per Beneficiary 0.0374 0.197 0 4   
  Physician-Level Characteristics (n=44,867)           
     Female (%) 22.64 NA NA NA   
     Age (%)           
        Under 40 Years 18.57 NA NA NA   
        40-50 Years 28.33 NA NA NA   
        51-60 Years 28.63 NA NA NA   
        Over 60 Years 24.47 NA NA NA   
     US Trained (%) 83.19 NA NA NA   
     Doctor of Osteo. (%) 9.7 NA NA NA   
  Network Characteristics (n=417)           
     Physician Female (%) 23.32 8.58 0 61.53   
     Physician US Trained (%) 76.61 11.15 30.43 100   
     Physician DO (%) 11.12 10.39 0 70.32   
     Physician Board Certified (%) 80.41 11.58 21.74 100   
     PCP (%) 43.82 0.14 4.54 100   
     "At-Risk" Beneficiaries Per PPC 982.7 715.21 6.00 3689   
     Physicians Per PPC (w/at-risk bene.) 107.62 79.53 6.00 473   
     Mean Adjusted Valued Degree 3.69 2.27 0.713 15.07   
     Betweeness-Centrality Ratio 0.717 0.23 0.069 1.915   
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Table 4: Descriptive Statistics  for the "At-Risk for LVS#3" Beneficiaries and Physicians 
Assigned to a PPC   
    Mean SD Minimum Maximum   
  Patient Level Characteristics (n=100,690)           
     Age 89.49 3.25 86 112   
     Female (%) 70.95 NA NA NA   
     Dual Eligible (min 1 mo.) (%) 19.51 NA NA NA   
     Race           
        White 95 NA NA NA   
        Black 3.76 NA NA NA   
        Hispanic 0.21 NA NA NA   
        Asian/Pacific Islander 0.54 NA NA NA   
        American Indian/Alaska Native 0.19 NA NA NA   
        Other Race/Ethnicity 0.1 NA NA NA   
     Mean LVS (#3) Per Beneficiary 0.0361 0.216 0 9   
  Physician-Level Characteristics (n=26,538)           
     Female (%) 20.24 NA NA NA   
     Age (%)           
        Under 40 Years 17.41 NA NA NA   
        40-50 Years 29.36 NA NA NA   
        51-60 Years 31.51 NA NA NA   
        Over 60 Years 21.73 NA NA NA   
     US Trained (%) 82.35 NA NA NA   
     Doctor of Osteo. (%) 89.28 NA NA NA   
  Network Characteristics (n=416)           
     Physician Female (%) 23.31 8.59 0 61.54   
     Physician US Trained (%) 76.62 11.15 30.43 100   
     Physician DO (%) 11.15 10.39 0 70.32   
     Physician Board Certified (%) 80.42 11.6 21.74 100   
     PCP (%) 43.88 14.1 4.55 100   
     "At-Risk" Beneficiaries Per PPC 242.04 175.31 2.00 919   
     Physicians Per PPC (w/at-risk bene.) 63.8 43.77 2.00 241   
     Mean Adjusted Valued Degree 3.679 2.26 0.713 15.07   
     Betweeness-Centrality Ratio 0.743 0.22 0.688 1.915   
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Analysis 
 To answer our research question, we first tested for variation of LVS usage 
amongst physician networks, and furthermore, conducted multivariate regression 
analysis to test network-level characteristics for significant association with the 
dependent variable. In order to test for variance of low-value cancer screening service 
usage across networks for each of the three at-risk populations, we tested for joint-
significance of network fixed effects in a negative binomial regression model 
(multiple variations of models tested to adjust for the distribution of outcome variable 
“LVS Count” for each beneficiary), adjusting for both patient and physician 
characteristics. The unit of analysis was at the beneficiary level, where each 
beneficiary was assigned a count (0-x) for the number of low-value services they 
received in each respective population group. A statistically significant result (p<.01) 
of joint-significance was found for networks amongst populations 1 and 2, suggesting 
that physician networks matter and are associated with the usage of these two cancer 
screening services. We did not find statistical significance for population 3, which we 
hypothesize might be due to the clinical nature of the screening service; those 
networks with a greater proportion of gastroenterologists were more likely to deliver 
LVS #3 at an aggregated network level but not at the beneficiary level analysis we are 
interested in.  
 In an effort to further explore the association of physician networks and the 
usage of cancer screening LVS, we ran a multivariate regression analysis with state-
fixed effects and included physician network-level characteristics (replacing the 
network-level fixed effects from the prior model). To control for the high variation in 
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LVS usage amongst networks with a low proportion of beneficiaries at-risk for a LVS, 
we restricted our analysis population to only those networks with at least 100 
beneficiaries at risk for each respective LVS population, which did not substantially 
alter the descriptive statistics of Tables 2-4. Population 3 network characteristics were 
not significantly related to the dependent variable (Count LVS #3 for each 
beneficiary), which while unexplained in our analysis might be the result of: A.) a low 
prevalence of these services; and B.) an abnormal distribution of gastroenterologists 
(and generally a low population of gastroenterologists) amongst networks in this 
study. 
 Results from our multivariate regression analysis (tables 5-7) for populations 1 
and 2 suggest that the percentage of US trained physicians (vs. Foreign) and the 
percentage of MD physicians (vs. DO) in a network are both inversely related to the 
amount of low-value cancer screening services delivered by the network. Population 1 
and Population 2 results indicate that physician networks with a one standard 
deviation greater than average US trained physician percentage, delivered LVS 1 and 
LVS 2, 9.05% and 1.22% less than the population mean, respectively. Further, 
Population 1 and population 2 results indicate that physician networks with a one 
standard deviation greater than the mean percentage of DO’s, delivered LVS 1 and 
LVS 2 11.09% and 32.26% more than the population mean, respectively. Statistical 
significance of Mean Adjusted-Valued Degree (p<.01) was found in population 1, and 
statistical significance of the betweeness-centrality ratio (p<.01) was found in 
population 2, suggesting that measures of network patient-sharing and network 
“closeness” might be associated with LVS usage. The percentage of Board-certified 
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physicians amongst networks delivering LVS #2 was associated (p<.01), such that an 
increase of one standard deviation in Board-Certified physicians compared to the 
mean resulted in a 17% increase of LVS delivery compared to the population mean. 
 
 
Beneficiaries                (N= 113,811) Marginal Effect † SD (ME)
Change in LVS Usage Per 
100 Beneficiaries Per 
Year ‡
Change in LVS Usage Per 100 
Beneficiaries Per Year as a % of 
Mean LVS Per 100 Bene. Per Year 
(%) ¥
Patient Level Characteristics
   Age -0.0064*** 4.7280 -3.03 -22.86%
   Female NA NA NA
   Dual Eligible (min 1 mo.) -0.0493*** NA -4.93 -37.19%
   Race
      Black  0.0122 NA 1.22 9.20%
      Hispanic -0.0054 NA -0.54 -4.07%
      Asain/Pacific Islander  0.01 NA 1 7.54%
      American Indian/Alaska Native -0.0194 NA -1.94 -14.63%
      Other Race/Ethnicity -0.0240 NA -2.4 -18.10%
Physician-Level Characteristics
   Female  0.0103* NA 1.03 7.77%
   Age**
      40-50 Years -0.0078 NA -0.78 -5.88%
      51-60 Years -0.0122** NA -1.22 -9.20%
      Over 60 Years  0.0014 NA 0.14 1.06%
   ForeignTrained  0.0144*** NA 1.44 10.86%
   Doctor of Osteo.  0.0173*** NA 1.73 13.05%
Network Characterisitcs
   Physician Female (%)  0.1477** 0.0600 0.89 6.71%
   Physician US Trained (%) -0.1187** 0.1010 -1.2 -9.05%
`    Physician DO (%)  0.1636* 0.0900 1.47 11.09%
   Physician Board Certified (%) -0.0678 0.0960 -0.65 -4.90%
   PCP (%) -0.1178 0.0910 -1.07 -8.07%
   Physicians Per PPC  0 147.3410 ~
   Mean Adjusted Valued Degree -0.0069*** 2.0350 -1.40 -10.56%
   Betweeness-Centrality Ratio  0.5526 0.0100 0.55 4.15%
*p<.10; **p<.05; ***p<.01.
¥The mean LVS(#1) per 100 beneficiaries per year amongst the total "at-risk" population is 13.256
"Race" reference group is White
"Foreign Trained" reference group is "U.S. Trained"
"Doctor of Osteo." reference group is MD
Table 5: Multivariate Analysis of Variables Association with LVS #1 (PSA Testing)
† The marginal eﬀect is the change in Low-Value Service (#1) per beneﬁciary per year for a 1 unit change in the variable, when the variable is 
continuous, or for a change from the reference category to the category listed, when the variable is categorical.
‡ This is the change in Low-Value Service (#1) usage per 100 beneﬁciaries for a 1 SD change in conLnuous variables, or for a change from the 
reference category to the category listed for categorical variables. Continuous variables are multiplied by the SD and expressed on a per 100 
beneficiaries basis.
 17 
 
 
 
 
 
Beneficiaries (N= 409,786)
Marginal Effect 
† SD
Change in LVS Usage 
Per 100 Beneficiaries 
Per Year ‡
Change in LVS Usage Per 100 
Beneficiaries Per Year as a % of 
Mean LVS Per 100 Bene. Per Year (%) 
¥
Patient Level Characteristics
   Age -0.0027*** 0.0002 0.0001 0.00%
   Female ~ ~ ~ ~
   Dual Eligible (min 1 mo.) -0.0164*** NA -1.64 -45.45%
   Race
      Black -0.0093*** NA -0.93 -25.78%
      Hispanic -0.0024 NA -0.24 -6.65%
      Asain/Pacific Islander -0.0009 NA -0.09 -2.49%
      American Indian/Alaska Native   0.0036 NA 0.36 9.98%
      Other Race/Ethnicity -0.0157** NA -1.57 -43.51%
Physician-Level Characteristics
   Female   0.0069*** NA 0.69 19.12%
   Age**
      40-50 Years   0.0014 NA 0.14 3.88%
      51-60 Years   0.0023 NA 0.23 6.37%
      Over 60 Years   0.0082*** NA 0.82 22.73%
   ForeignTrained   0.0052*** NA 0.52 14.41%
   Doctor of Osteo. -0.0020 NA -0.20 -5.54%
Network Characterisitcs
   Physician Female (%) -0.1040 0.0318 -0.33072 -9.17%
   Physician US Trained (%) -0.0226*** 0.0194 -0.0438 -1.22%
   Physician DO (%)   0.3604*** 0.0323 1.1641 32.26%
   Physician Board Certified (%)   0.2005*** 0.0306 0.6135 17.00%
   PCP (%) -0.0374 0.0231 -0.0864 -2.39%
   Bene. Per PPC ~ ~ ~
   Mean Adjusted Valued Degree -0.0015 0.0011 0.00 0.00%
   Betweeness-Centrality Ratio   0.0353*** 0.0120 0.04236 1.17%
*p<.10; **p<.05; ***p<.01.
¥The mean LVS(#2) per 100 beneficiaries per year amongst the total "at-risk" population is 3.608
"Race" reference group is White
"Foreign Trained" reference group is "U.S. Trained"
"Doctor of Osteo." reference group is MD
Table 6: Multivariate Analysis of Variables Association with LVS #2 (Cervical Cancer testing)
† The marginal eﬀect is the change in Low-Value Service (#1) per beneﬁciary per year for a 1 unit change in the variable, when the 
variable is continuous, or for a change from the reference category to the category listed, when the variable is categorical.
‡ This is the change in Low-Value Service (#1) usage per 100 beneﬁciaries for a 1 SD change in conLnuous variables, or for a change 
from the reference category to the category listed for categorical variables. Continuous variables are multiplied by the SD and 
expressed on a per 100 beneficiaries basis.
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Beneficiaries (N= 100,690)
Marginal 
Effect † SD
Change in LVS Usage 
Per 100 Beneficiaries 
Per Year ‡
Change in LVS Usage Per 100 
Beneficiaries Per Year as a % of Mean 
LVS Per 100 Bene. Per Year (%) ¥
Patient Level Characteristics
   Age -0.003*** 0.0020 -0.0006 -0.02%
   Female -0.0138 0.0017  0.002346 0.08%
   Dual Eligible (min 1 mo.) -0.0027 NA -0.2700 -8.95%
   Race
      Black  0.0056 NA  0.5625 18.64%
      Hispanic  0.0200 NA  2.0014 66.32%
      Asain/Pacific Islander -0.0136** NA -1.3610 -45.10%
      American Indian/Alaska Native  0.0212 NA  2.1239 70.37%
      Other Race/Ethnicity  0.0094 NA  0.9421 31.22%
Physician-Level Characteristics
   Female -0.0008 NA -0.0763 -2.53%
   Age**
      40-50 Years  0.001 NA  0.1072 3.55%
      51-60 Years  0.0024 NA  0.2419 8.02%
      Over 60 Years -0.0025 NA -0.2493 -8.26%
   ForeignTrained  0.006*** NA  0.5969 19.78%
   Doctor of Osteo. -0.0019 NA -0.1944 -6.44%
Network Characterisitcs
   Physician Female (%) -0.0032 0.0205 -0.0061 -0.20%
   Physician US Trained (%) -0.0110 0.0142 -0.0157 -0.52%
   Physician DO (%) -0.0051 0.0120 -0.0100 -0.33%
   Physician Board Certified (%) -0.0031 0.0209 -0.0065 -0.22%
   PCP (%) 0.0174 0.0173  0.0299 0.99%
   Bene. Per PPC ~ ~ ~ ~
   Mean Adjusted Valued Degree -0.0001 0.0006  0 0.00%
   Betweeness-Centrality Ratio  0.0128 0.0102  0.0131 0.43%
*p<.10; **p<.05; ***p<.01.
¥The mean LVS(#3) per 100 beneficiaries per year amongst the total "at-risk" population is 3.018
"Race" reference group is White
"Foreign Trained" reference group is "U.S. Trained"
"Doctor of Osteo." reference group is MD
Table 7: Multivariate Analysis of Variables Association with LVS #3 (Colon Cancer Screening)
† The marginal eﬀect is the change in Low-Value Service (#1) per beneﬁciary per year for a 1 unit change in the variable, when the 
variable is continuous, or for a change from the reference category to the category listed, when the variable is categorical.
‡ This is the change in Low-Value Service (#1) usage per 100 beneﬁciaries for a 1 SD change in conLnuous variables, or for a change 
from the reference category to the category listed for categorical variables. Continuous variables are multiplied by the SD and 
expressed on a per 100 beneficiaries basis.
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DISCUSSION 
In agreement with prior research on physician practice communities (referred 
to as physician networks in this paper), we found that networks have an association 
with the cost of healthcare—in this case specifically we found that networks vary 
significantly in their usage of low-value cancer screening services when adjusting for 
patient and physician characteristics. Amongst a total study population of 987,000 
Medicare beneficiaries, we identified three populations of beneficiaries who were at-
risk for receiving at least one of three low-value cancer screening services (as defined 
by the literature) and were assigned to a physician network as defined by Casalino, et 
al.. Our findings strongly suggest that there is an association between a physician 
network’s physician composition in predicting its’ usage of low-value cancer 
screening services. The percentage of physicians practicing in a network with an MD, 
and those who were trained in the United States was significantly related to a reduced 
usage from the population mean of two of the three low-value cancer screening 
services we studied (Prostate-Specific Antigen testing, and Cervical Cancer Screening 
amongst at-risk populations). We also conclude that certain measures of physician 
networks, such as the closeness of physicians (patient sharing frequency) and the 
centrality of the average physician in a network (how many physicians the average 
physician refers patients to) may be a key to understanding the patterns of low-value 
care across networks.  
The field of social network theory suggests that social networks may underpin 
certain physician practice patterns, resulting in differences in the cost and quality of 
care even if we control for individual patient and physician characteristics. Although 
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our findings lend credence to this theory, we cannot claim that there is a causal 
relationship between the composition and characteristics of a physician network with 
the delivery of low-value services without further research. Furthermore, our data are 
derived from 2008 Medicare claims, so the patterns discovered in this research may 
not be representative of today’s healthcare market practice patterns which have 
notably progressed in response to pay-for-performance initiatives and alternative 
payment models introduced by both commercial and public payers. We recommend 
further study of low-value service patterns of delivery, as the results may arm payers, 
physician practices, and policymakers with important information which results in 
precisely targeted policy initiatives which reduce wasteful spending on low-value 
services.  
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